Erythroblast island

Same author

Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers.

Cell death & disease·2018

Same author

Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance.

Molecular cancer research : MCR·2016

Same author

Blastic plasmacytoid dendritic cell neoplasm with extensive cutaneous and central nervous system involvement.

Rare tumors·2015

Same author

Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research.

Breast cancer research and treatment·2014

Same author

Everolimus-induced hematologic changes in patients with metastatic breast cancer.

Clinical breast cancer·2014

Same author

Metastatic angiosarcoma and kasabach-merritt syndrome.

Rare tumors·2014

Same journal

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Haematologica·2026

Same journal

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Haematologica·2026

Same journal

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Haematologica·2026

Same journal

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Haematologica·2026

Same journal

Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

Haematologica·2026

Same journal

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

Haematologica·2026

Related Experiment Videos

Erythroblast island

Related Concept Videos

Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers.

Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance.

Blastic plasmacytoid dendritic cell neoplasm with extensive cutaneous and central nervous system involvement.

Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research.

Everolimus-induced hematologic changes in patients with metastatic breast cancer.

Metastatic angiosarcoma and kasabach-merritt syndrome.

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

Related Experiment Videos

Erythroblast island

Related Concept Videos

Related Articles

Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers.

Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance.

Blastic plasmacytoid dendritic cell neoplasm with extensive cutaneous and central nervous system involvement.

Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research.

Everolimus-induced hematologic changes in patients with metastatic breast cancer.

Metastatic angiosarcoma and kasabach-merritt syndrome.

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.